BioRestorative Therapies to Provide Third Quarter 2025 Financial Overview
BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a leading innovator in regenerative medicine with a focus on stem cell-based therapies, has revealed plans to issue its financial results for the third quarter of 2025. The announcement will take place after market close on the designated day, followed by a conference call where management will discuss the results and offer insights into the Company’s ongoing business initiatives.
Conference Call Details
Investors and analysts are invited to partake in a comprehensive review of BioRestorative Therapies' performance and future direction during the upcoming conference call. Here are the essential details:
Date
Scheduled for Wednesday, November 12, 2025.
Time
The call will commence at 4:30 p.m. ET.
Access Details
Participants can join the call using the following numbers:
- Domestic: 1-888-506-0062
- International: 1-973-528-0011
When prompted, use access code 464585 to enter the call.
For those unable to join live, the call will be recorded and accessible through the Company’s website in the Investors section.
About BioRestorative Therapies, Inc.
BioRestorative is dedicated to engineering groundbreaking therapeutic products through innovative cell and tissue protocols, with a particular emphasis on adult stem cells. The Company’s development programs are primarily focused on two areas: treatment for disc/spine disease and addressing metabolic disorders, alongside a growing commercial BioCosmeceutical portfolio.
Disc/Spine Program (brtxDISC™)
The cornerstone of BioRestorative's clinical advancements is the BRTX-100, developed from the individual patient’s own cultured mesenchymal stem cells harvested from their bone marrow. BRTX-100 aims to offer non-surgical relief for lumbosacral disc disorders and serve as a complementary therapy following surgical interventions. Utilization of proprietary technology ensures a refined process of cell collection, culture, and preservation. The product, intended for outpatient use, is injected into the damaged disc after extensive clinical evaluations. Presently, a Phase 2 clinical trial is ongoing to assess its efficacy in alleviating chronic lower back pain stemming from degenerative disc disease.
Metabolic Program (ThermoStem)
BioRestorative is actively pursuing novel therapies that target obesity and metabolic issues using brown adipose-derived stem cells. This initiative is intended to recreate the effects of brown adipose tissue, which is known for its role in metabolic regulation. Early-stage preclinical data suggests that an increase in brown fat correlates with improved caloric expenditure and favorable changes in glucose and lipid levels – presenting an essential avenue for combating obesity and diabetes. The cellular exosomes from these stem cells add another layer of potential for influencing weight management.
BioCosmeceuticals
The commercial undertakings include pioneering a BioCosmeceutical platform, which currently features a scientifically advanced product created in a cGMP ISO-7 certified clean room. This distinctive serum, rich in exosomes and growth factors, is crafted to enhance cosmetic outcomes, focusing on minimizing fine lines and wrinkles. Future plans encompass expanding this product line to include a diverse array of aesthetic therapies designed to meet the evolving preferences of the market.
Frequently Asked Questions
What is the purpose of the upcoming conference call?
The conference call will share BioRestorative's third-quarter financial results and update stakeholders on the company's business strategies.
When will BioRestorative release its Q3 financial results?
The financial results will be announced after the market closes on November 12, 2025.
How can I participate in the conference call?
You can join by calling either the domestic or international access numbers and using the access code provided.
What are the main focuses of BioRestorative's therapy programs?
BioRestorative concentrates on treatments for spine disorders and metabolic diseases, along with developing innovative cosmetic products.
Where can I find more information about the company?
Further details are available on BioRestorative's official website in the Investors section.
